FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA supplemental application for Linzess (linaclotide) submitted by Allergan to modify labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linzess (linaclotide)

Snippet

SUPPL AP for LINZESS (LINACLOTIDE)